NCT00002881View on ClinicalTrials.gov

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1996

Primary Completion Date

April 30, 1998

Conditions
Prostate Cancer
Interventions
DRUG

flutamide

DRUG

goserelin acetate

DRUG

leuprolide acetate

DRUG

suramin

DRUG

therapeutic hydrocortisone

PROCEDURE

orchiectomy

Trial Locations (1)

20307-5000

Walter Reed Army Medical Center, Washington D.C.

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Cancer and Leukemia Group B

NETWORK

collaborator

SWOG Cancer Research Network

NETWORK

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00002881 - Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter